Increasing resistance of Streptococcus pneumoniae to fluoroquinolones:: results of a Hong Kong multicentre study in 2000

被引:195
作者
Ho, PL
Yung, RWH
Tsang, DNC
Que, TL
Ho, M
Seto, WH
Ng, TK
Yam, WC
Ng, WWS
机构
[1] Univ Hong Kong, Queen Mary Hosp, Div Infect Dis, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Sch Profess & Continuing Educ, Hong Kong, Hong Kong, Peoples R China
[3] Pamela Youde Nethersole E Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
[5] Tuen Mun Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
[6] Kwong Wah Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
[7] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[8] Princess Margaret Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1093/jac/48.5.659
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The MICs of 13 antimicrobial agents including seven fluoroquinolones (ciprofloxacin, levofloxacin, sparfloxacin, grepafloxacin, gatifloxacin, moxifloxacin and clinafloxacin) for Streptococcus pneumoniae isolates obtained from all regions of Hong Kong in the year 2000 were determined by the Etest. Overall, 39.4% of 180 isolates were susceptible to penicillin, 11.7% were intermediate and 48.9% were resistant. The overall prevalence of fluoroquinolone non-susceptibility (levofloxacin MIC greater than or equal to 4 mg/L) was 13.3% but increased to 27.3% among the penicillin-resistant isolates. For the fluoroquinolone non-susceptible isolates, within-class cross-resistance was common. For the fluoroquinolone non-susceptible isolates, the median MICs of clinafloxacin, gatifloxacin, moxifloxacin, sparfloxacin and grepafloxacin were, respectively, six-, 24-, 32- 84- and 128-fold higher than those for the susceptible isolates. All fluoroquinolone non-susceptible strains were derived from adults. The prevalence of fluoroquinolone resistance was higher in isolates from older patients (17.1% among those greater than or equal to 65 years of age versus 9.1% among those 18-64 years of age, P < 0.001) and from adults with chronic obstructive pulmonary disease (24.6% versus 9.3%, P = 0.01). All fluoroquinolone non-susceptible strains were non-susceptible to penicillin (MIC range 2-4 mg/L), cefotaxime (MIC range 1-4 mg/L) and erythromycin (MIC range 4-greater than or equal to 256 mg/L). The fluoroquinolone non-susceptible isolates were genetically related to the Spain (23F)-1 clone when analysed by pulse-field gel electrophoresis and multilocus sequence typing. In conclusion, a rapid increase in the prevalence of fluoroquinolone resistance among S. pneumoniae was found in Hong Kong. Typing analysis suggests that this is due to the pan-regional dissemination of a fluoroquinolone-resistant variant (designated Hong Kong(23F)-l) of the globally distributed Spain (23F)-1 clone.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 22 条
[1]  
[Anonymous], PERF STAND ANT SUSC
[2]  
AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
[3]  
CHEAH I, 2000, MIMS HONG KONG, V29
[4]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[5]   Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis [J].
Chodosh, S ;
Schreurs, A ;
Siami, G ;
Barkman, HW ;
Anzueto, A ;
Shan, M ;
Moesker, H ;
Stack, T ;
Kowalsky, S .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :730-738
[6]   Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999) [J].
Deshpande, LM ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (02) :139-142
[7]   The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada -: 1997 results from the SENTRY Antimicrobial Surveillance Program [J].
Doern, GV ;
Pfaller, MA ;
Erwin, ME ;
Brueggemann, AB ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) :313-316
[8]   Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland [J].
Goldsmith, CE ;
Moore, JE ;
Murphy, PG ;
Ambler, JE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (03) :420-421
[9]   Penicillin-resistant Streptococcus pneumoniae:: selection by both β-lactam and non-β-lactam antibiotics [J].
Goldstein, FW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) :141-144
[10]   Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong [J].
Ho, PL ;
Que, TL ;
Tsang, DNC ;
Ng, TK ;
Chow, KH ;
Seto, WH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1310-1313